Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Neuropathy (Small Fiber Predominant, SFN)

NCT06980948 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Neuropathic Pain

Interventions

GENETIC: ST-503
PROCEDURE: Sham (No Treatment)

Sponsor

Sangamo Therapeutics